Cytrellis Recognized As Finalist For Prestigious Innovation Of The Year Award
Cytrellis competed in “Innovation Shark Tank” during IMCAS’ Global Market Summit, and was named first runner-up for IMCAS Innovation of the Year and awarded IMCAS Promising Innovation 2020!
Read More
Top Aesthetic Trends To Expect In 2020, According To Dermatologists And Plastic Surgeons
As seen in NewBeauty
New York dermatologist Doris Day, MD calls the fractional facelift the “most exciting and revolutionary of all of the new rejuvenation technology….ever!” According to Dr. Day, the treatment relies on micro-coring of skin—a technique where “anywhere from dozens to hundreds of tiny, full thickness cores of the skin are removed”—which leaves bridges of normal skin between them, “allowing for skin contraction and a veritable lift, without surgery and with very little downtime.”
Read More
Novel Dermal Micro-Coring® Device Holds Promise For Moderate To Severe Wrinkle
As seen in Dermatology News
An investigative dermal Micro-Coring® device designed for improvement of moderate to severe facial wrinkles and tightening is poised to become a game-changer in the minimally invasive aesthetics field…
Read More
The New Non-Surgical Facelift: Can Dermal Micro-Coring® Come Close To Surgery?
The Next 25 Years In Beauty
As seen in Marie Claire
“In 2 years, you won’t need surgery to give your face a lift”… The Cytrellis treatment “is like a facelift by a thousand small cuts instead of a few big ones, but there’s no scarring and the results are subtler,” says Dr. Mathew Avram, faculty director of the Dermatology Laser and Cosmetic Center at Massachusetts General Hospital. “Trials are underway now.”
Read More
Cytrellis Completes $28.5 Million Series B Financing
Cytrellis announced today that it has received $28.5 million in a Series B round which included existing investors ARCH Venture Partners, the Merz Venture Initiative and new investors, Partner Fund Management and Biomatics Captial.
Read More